CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.15

EPS Forecast

$4.04

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Proximilar's AI forecasts

EPS Forecast:

-$1.15

Revenue Forecast:

$4.04

EPS Surprise Forecast:

-$0.004

Revenue Surprise Forecast:

-$3

Post-release price volatility - High

Post-release Overnight Move:

±7.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

52%

Probability of beating revenue consensus:

30%

Probability of beating both EPS & revs consensus:

21%

Probability of missing both EPS & revs consensus:

39%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-5

Beta (β)

Forward Looking Beta (β):

2.00

Earnings volatility

EPS standard deviation:

$0.28

Revenue standard deviation:

$12

As % of share price:

0.59% VERY HIGH

As % of market cap:

0.27% LOW

Confidence intervals and percentiles

EPS 95th %ile:

-$0.78

Revenue 95th %ile:

$20

EPS 75th %ile:

-$1.05

Revenue 75th %ile:

$8

EPS 25th %ile:

-$1.22

Revenue 25th %ile:

$0

EPS 5th %ile:

-$1.45

Revenue 5th %ile:

-$9

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

40% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

86% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$17

Bid-ask per Share:

$0.08